Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response

E Kindler1, V Thiel1, F Weber2

  • 1University of Bern, Bern, Switzerland; Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland.

Insights

Highly pathogenic coronaviruses like SARS-CoV and MERS-CoV evade the human interferon response. This review details their strategies for replication despite host antiviral defenses.

Area of Science:

  • Virology and Immunology
  • Infectious Diseases

Background:

  • Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are severe human diseases caused by zoonotic coronaviruses (CoVs).
  • These highly pathogenic CoVs can overcome robust host defense mechanisms, including the critical antiviral interferon system.

Purpose of the Study:

  • To review recent advancements in understanding how pathogenic coronaviruses counteract host antiviral immunity.
  • To elucidate the specific strategies employed by SARS-CoV and MERS-CoV to evade or inhibit the interferon response in human cells.

Main Methods:

  • Literature review of recent research on coronavirus pathogenesis and host-pathogen interactions.
  • Analysis of molecular mechanisms by which SARS-CoV and MERS-CoV interfere with the interferon signaling pathway.

Main Results:

  • Coronaviruses encode numerous factors that facilitate replication in the face of host defenses.
  • Specific viral strategies target and suppress the interferon antiviral response.

Conclusions:

  • Understanding these viral evasion tactics is crucial for developing effective countermeasures against SARS and MERS.
  • Further research into coronavirus-interferon interactions can inform therapeutic strategies for severe respiratory infections.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
432
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
81
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K
RNA Interference01:23

RNA Interference

7.8K